샘플 요청 목록

 카트 문의
시장보고서
상품코드
1798199

세계의 PET 방사성 트레이서 시장

PET Radiotracers
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 383 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 PET 방사성 트레이서 시장은 2030년까지 59억 달러에 도달

2024년에 37억 달러로 추정되는 세계의 PET 방사성 트레이서 시장은 2024-2030년에 CAGR 8.4%로 성장하며, 2030년에는 59억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 F-18 방사성 트레이서는 CAGR 9.6%를 기록하며, 분석 기간 종료까지 42억 달러에 달할 것으로 예측됩니다. Ga 68 방사성 트레이서 부문의 성장률은 분석 기간에 CAGR 5.5%로 추정되고 있습니다.

미국 시장은 9억 9,920만 달러로 추정, 중국은 CAGR 13.2%로 성장 예측

미국의 PET 방사성 트레이서 시장은 2024년에 9억 9,920만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 13억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 13.2%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 4.1%와 8.0%로 예측됩니다. 유럽에서는 독일이 CAGR 5.6%로 성장할 것으로 예측됩니다.

세계의 PET 방사성 트레이서 시장 - 주요 동향과 촉진요인 정리

PET 방사성 추적자가 현대 영상 진단에서 견인차 역할을 하는 이유는 무엇인가?

양전자방사선단층촬영(PET) 방사성 추적자는 특히 종양학, 신경학, 심장병학에서 첨단 영상 진단의 기초가 되는 툴이 되고 있습니다. 이러한 방사성 의약품은 양전자 방출 동위원소로 표지된 생물학적 활성 분자로, 임상의는 세포 수준에서 대사 및 분자 활동을 시각화할 수 있습니다. 구조적 영상 진단과 달리 PET 검사는 질병의 진행, 조기 발견, 치료 효과에 대한 기능적 인사이트를 제공함으로써 정밀의료에 필수적인 역할을 하고 있습니다.

세계 PET 방사성 트레이서 시장은 암 발병률 증가, 임상 적용 확대, 3차 의료시설의 PET-CT 및 PET-MRI 하이브리드 시스템 통합으로 인해 강력한 성장세를 보이고 있습니다. 암 분야는 여전히 주요 용도이며, 임상용으로는 18F-FDG(Fluorodeoxyglucose)가 가장 큰 점유율을 차지하고 있습니다. 그러나 신경내분비종양에 대한 68Ga-DOTATATE나 전립선암 재발에 대한 18F-fluciclovine과 같은 새로운 추적자는 진단 상황을 빠르게 다양화시키고 있습니다.

또한 사이클로트론 시설과 방사성 의약품 네트워크 등 핵의학 인프라에 대한 투자가 증가하면서 PET 트레이서에 대한 지역적 접근성이 향상되고 있습니다. 미국, 유럽, 아시아태평양의 규제기관은 임상시험용 방사성 의약품의 승인 절차를 간소화하여 임상시험과 상업적 출시를 가속화하고 있습니다. 산학협력에 기반한 이 생태계의 성장이 기존 암 진단약에 국한되지 않는 세계 PET 방사성동위원소 시장을 촉진하고 있습니다.

기술 발전이 방사성 추적자 개발 및 전달에 어떤 영향을 미치고 있는가?

PET용 방사성 추적자의 기술 혁신은 동위원소 제조, 방사화학 자동화, 추적자 특이적 타겟팅 메커니즘의 발전에 크게 의존하고 있습니다. 사이클로트론의 소형화와 발전기 기반 동위원소 시스템(예: 68Ge/68Ge/68Ga 발전기)의 도입으로 방사성 추적자의 현장 또는 현장 근접 생산이 용이해져 기존 중앙집중식 공급망의 반감기 관련 제약이 완화되었습니다. 이는 특히 신흥 시장과 원격지의 의료시설에서 접근성을 확대하는 데 도움이 되고 있습니다.

현재, 표적 방사성 추적자는 수용체 특이성을 높이기 위해 설계되어 임상의가 종양의 아형을 구별하고 분자 수준에서 치료 효과를 모니터링할 수 있도록 돕고 있습니다. 예를 들어 18F-FES는 유방암의 에스트로겐 수용체를 표적으로 삼고, PSMA 리간드 기반 추적자는 전립선암의 진단 및 치료법을 재구성하고 있습니다. 신경학에서는 18F-florbetapir와 18F-fortaucipir가 알츠하이머병에서 아밀로이드와 타우의 병태를 영상화하여 조기 인지기능 저하 진단을 지원하는 데 사용되고 있습니다.

카세트 기반 합성 모듈이나 마이크로플루이딕스 칩과 같은 방사성 추적자 합성 자동화 플랫폼은 인적 오류를 줄이고 순도를 높이며 생산 시간을 단축하고 있습니다. 또한 방사성 의약품 제조업체들은 절차를 표준화하고 의료진의 방사선 피폭 위험을 줄이기 위해 콜드키트 및 즉시 사용 가능한 주사제 개발에도 힘쓰고 있습니다. 방사성 의약품이 질병별 진단 요구에 대응할 수 있도록 진화함에 따라 기술은 확장성, 효율성, 안전성을 실현하는 중요한 요소로 자리 잡고 있습니다.

시장 확대를 주도하는 임상 용도와 지역은?

종양학이 PET 방사성 트레이서의 핵심 시장인 반면, 신경과와 순환기학의 새로운 적응증이 견인차 역할을 하고 있습니다. 알츠하이머병 진단에서 아밀로이드 및 타우 PET 이미징의 채택이 증가하고 있으며, 질병 변형 치료제의 승인에 힘입어 새로운 성장 경로가 생겨나고 있습니다. 마찬가지로 13N-암모니아나 82Rb와 같은 관류 추적자를 이용한 심장 PET 영상도 복잡한 관상동맥 질환 환자의 심근 생존율과 허혈을 평가하는 데 도움이 되고 있습니다.

지역적으로 북미는 강력한 방사성 의약품 제조거점이 있고, 1인당 의료비 지출이 높으며, 첨단 이미징 센터가 존재하므로 여전히 지배적인 시장입니다. 미국 FDA는 Drug Master File 제도와 Radioactive Drug Research Committee(RDRC) 프레임워크와 같은 구상을 통해 방사성 추적자 개발을 지원하고 있으며, 기술 혁신을 촉진하고 있습니다. 독일, 영국, 프랑스는 핵의학 분야가 확립되어 있고, PET-MRI 설비가 증가하고 있으며, 도입 곡선을 선도하고 있습니다.

아시아태평양은 가장 빠르게 성장하는 지역으로 일본, 중국, 한국과 같은 국가들이 국내 동위원소 생산에 투자하고 PET 이미징 인프라를 확장하고 있습니다. 인도에서는 특히 3차 암센터에서 PET 트레이서 개발을 위한 민관 파트너십이 증가하고 있습니다. 라틴아메리카와 중동 일부 지역에서는 인프라 격차와 높은 조달 비용으로 인해 제한적이지만 초기 도입 조짐을 보이고 있습니다.

세계 PET 방사성 트레이서 시장의 성장을 주도하는 요인은?

세계 PET 방사성 트레이서 시장의 성장을 촉진하는 요인으로는 암 및 신경 퇴행성 질환의 발병률 증가, 하이브리드 영상 진단 양식의 채택 확대, 핵의학 인프라의 급속한 확장, 질병을 표적으로 하는 추적기 설계의 지속적인 혁신 등이 있습니다. 정밀진단이 현대 의료의 핵심으로 떠오르면서, 정확하고 실용적인 조기 진단을 제공하는 방사선 추적기에 대한 수요가 급증하고 있습니다.

주요 성장 촉진요인으로는 방사성 의약품 연구개발에 대한 정부 지원, 규제 체계의 합리화, 방사화학 자동화의 발전 등을 꼽을 수 있습니다. 가치 기반 의료와 맞춤형 의료로의 임상적 전환은 병원들이 진단의 모호성을 줄이고 치료 결과를 향상시키는 분자 이미징 툴을 채택하도록 유도하고 있습니다. 민간 기업은 확대되는 방사성 추적자 파이프라인, 탄탄한 공급망, 표적 치료용 동반 진단약으로 대응하고 있습니다.

또한 교육 구상과 핵의학 교육 프로그램은 전 세계 방사성 약사 인력 풀을 강화하고 안전하고 규정을 준수하는 추적자 취급을 보장하는 데 도움을 주고 있습니다. 임상 전문 분야와 지역별로 수요가 계속 다양화되는 가운데, PET 방사성 트레이서 시장은 빠르게 성장하고 있으며, 차세대 의료 영상의학의 핵심으로 자리매김할 수 있는 좋은 위치에 있습니다.

부문

방사성 트레이서(F-18 방사성 트레이서, Ga 68 방사성 트레이서, 기타 방사성 트레이서 유형); 애플리케이션(암, 심장병, 소화기, 내분비, 신경질환, 기타); 최종사용자(병원, 진단 센터, 기타)

조사 대상 기업의 예

  • ABX Advanced Biochemical Compounds GmbH
  • Advanced Accelerator Applications
  • AstraZeneca PLC
  • Avid Radiopharmaceuticals
  • Blue Earth Diagnostics
  • Cardinal Health Inc.
  • Eli Lilly and Company
  • GE HealthCare
  • IBA Radiopharma Solutions S.A.
  • ImaginAb Inc.
  • IXICO PLC
  • Jubilant Pharma Limited
  • Lantheus Holdings Inc.
  • Neusoft Medical Systems Co. Ltd.
  • Nordion Inc.
  • Positron Corporation
  • Radiomedix Inc.
  • Siemens Healthineers AG
  • SOFIE Biosciences Inc.
  • Yantai Dongcheng Pharmaceutical

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계 고유 SLM에 쿼리 하는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 큐레이트된 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.09.04

Global PET Radiotracers Market to Reach US$5.9 Billion by 2030

The global market for PET Radiotracers estimated at US$3.7 Billion in the year 2024, is expected to reach US$5.9 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. F-18 Radiotracer, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$4.2 Billion by the end of the analysis period. Growth in the Ga 68 Radiotracer segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$999.2 Million While China is Forecast to Grow at 13.2% CAGR

The PET Radiotracers market in the U.S. is estimated at US$999.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 13.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.1% and 8.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global PET Radiotracers Market - Key Trends & Drivers Summarized

Why Are PET Radiotracers Gaining Traction in Modern Diagnostic Imaging?

Positron Emission Tomography (PET) radiotracers have become foundational tools in advanced diagnostic imaging, particularly in oncology, neurology, and cardiology. These radiopharmaceuticals, which are biologically active molecules labeled with positron-emitting isotopes, enable clinicians to visualize metabolic and molecular activity at a cellular level. Unlike structural imaging modalities, PET scans offer functional insights into disease progression, early detection, and treatment response, making them indispensable in precision medicine.

The global PET radiotracers market is experiencing robust growth due to increasing cancer prevalence, expanding clinical applications, and the integration of PET-CT and PET-MRI hybrid systems in tertiary healthcare facilities. Oncology remains the dominant application area, with 18F-FDG (fluorodeoxyglucose) accounting for the largest share of clinical usage. However, novel tracers like 68Ga-DOTATATE for neuroendocrine tumors and 18F-fluciclovine for prostate cancer recurrence are rapidly diversifying the diagnostic landscape.

Furthermore, rising investments in nuclear medicine infrastructure-such as cyclotron facilities and radiopharmacy networks-are improving regional accessibility to PET tracers. Regulatory bodies in the U.S., Europe, and Asia-Pacific have streamlined the approval process for investigational radiopharmaceuticals, accelerating clinical trials and commercial deployment. This growing ecosystem, supported by academic-industry collaboration, is propelling the global PET radiotracers market beyond conventional cancer diagnostics.

How Are Technological Advancements Influencing Radiotracer Development and Delivery?

PET radiotracer innovation is heavily reliant on advances in isotope production, radiochemistry automation, and tracer-specific targeting mechanisms. The miniaturization of cyclotrons and the deployment of generator-based isotope systems (e.g., 68Ge/68Ga generators) are facilitating onsite or near-site production of radiotracers, reducing the half-life-related limitations of traditional centralized supply chains. This has especially helped expand access in emerging markets and remote healthcare facilities.

Targeted radiotracers are now being designed with increased receptor specificity, allowing clinicians to differentiate between tumor subtypes and monitor treatment efficacy at the molecular level. For example, 18F-FES targets estrogen receptors in breast cancer, while PSMA-ligand-based tracers are reshaping prostate cancer diagnostics and theranostics. In neurology, 18F-florbetapir and 18F-flortaucipir are being used to image amyloid and tau pathology in Alzheimer's disease, supporting early-stage cognitive decline diagnostics.

Automation platforms for radiotracer synthesis, such as cassette-based synthesis modules and microfluidic chips, are reducing human error, enhancing purity, and accelerating production times. Radiopharmaceutical manufacturers are also working on cold kits and ready-to-use injectables to standardize procedures and reduce radiation exposure risks for medical staff. As radiotracers evolve to meet disease-specific diagnostic needs, technology is acting as the critical enabler of scalability, efficiency, and safety.

Which Clinical Applications and Geographic Regions Are Driving Market Expansion?

While oncology represents the core market for PET radiotracers, newer indications in neurology and cardiology are gaining traction. In Alzheimer's diagnostics, increased adoption of amyloid and tau PET imaging-supported by the approval of disease-modifying therapies-is creating new growth pathways. Similarly, cardiac PET imaging using perfusion tracers like 13N-ammonia and 82Rb is helping evaluate myocardial viability and ischemia in patients with complex coronary artery disease.

Geographically, North America remains the dominant market due to its strong radiopharmaceutical manufacturing base, high per capita healthcare spending, and the presence of advanced imaging centers. The U.S. FDA's support for radiotracer development under initiatives like the Drug Master File system and the Radioactive Drug Research Committee (RDRC) framework is expediting innovation. Europe is closely following, with Germany, the UK, and France leading the adoption curve due to well-established nuclear medicine departments and growing PET-MRI installations.

Asia-Pacific is emerging as the fastest-growing region, with countries like Japan, China, and South Korea investing in domestic isotope production and expanding their PET imaging infrastructure. India is witnessing increased public-private partnerships for PET tracer development, particularly in tertiary cancer centers. Latin America and parts of the Middle East are showing early signs of adoption, albeit limited by infrastructure gaps and high procurement costs.

What Is Driving Growth in the Global PET Radiotracers Market?

The growth in the global PET radiotracers market is driven by the rising incidence of cancer and neurodegenerative disorders, increasing adoption of hybrid imaging modalities, rapid expansion of nuclear medicine infrastructure, and continued innovation in disease-targeted tracer design. As precision diagnostics become central to modern healthcare, demand for radiotracers that provide early, accurate, and actionable insights is rising sharply.

Key growth drivers include government support for radiopharmaceutical R&D, streamlined regulatory frameworks, and advancements in radiochemistry automation. The clinical shift toward value-based care and personalized medicine is prompting hospitals to adopt molecular imaging tools that can reduce diagnostic ambiguity and improve therapeutic outcomes. Commercial players are responding with an expanding pipeline of radiotracers, robust supply networks, and companion diagnostics for targeted therapies.

Moreover, educational initiatives and nuclear medicine training programs are strengthening the global radiopharmacist talent pool, helping ensure safe and compliant tracer handling. As demand continues to diversify across clinical specialties and geographies, the PET radiotracers market is well-positioned to scale rapidly, anchoring its role as a cornerstone of next-generation medical imaging.

SCOPE OF STUDY:

The report analyzes the PET Radiotracers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Radiotracer (F-18 Radiotracer, Ga 68 Radiotracer, Other Radiotracer Types); Application (Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application, Other Applications); End-User (Hospitals End-User, Diagnostic Centers End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • ABX Advanced Biochemical Compounds GmbH
  • Advanced Accelerator Applications
  • AstraZeneca PLC
  • Avid Radiopharmaceuticals
  • Blue Earth Diagnostics
  • Cardinal Health Inc.
  • Eli Lilly and Company
  • GE HealthCare
  • IBA Radiopharma Solutions S.A.
  • ImaginAb Inc.
  • IXICO PLC
  • Jubilant Pharma Limited
  • Lantheus Holdings Inc.
  • Neusoft Medical Systems Co. Ltd.
  • Nordion Inc.
  • Positron Corporation
  • Radiomedix Inc.
  • Siemens Healthineers AG
  • SOFIE Biosciences Inc.
  • Yantai Dongcheng Pharmaceutical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • PET Radiotracers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Precision Oncology Throws the Spotlight on PET-Based Molecular Imaging Agents
    • Growth in Cancer Screening and Early Detection Programs Spurs Radiotracer Utilization
    • Expansion of Theranostics and Targeted Therapy Monitoring Drives Development of New PET Radiotracers
    • FDA Approvals of Novel PET Tracers for PSMA and Amyloid Imaging Accelerate Market Expansion
    • Increased Use of PET/CT and PET/MRI Hybrids Strengthens Business Case for Multi-Organ Tracers
    • Shift Toward Personalized Medicine Supports Companion Diagnostic Applications of Radiotracers
    • Technological Advancements in Cyclotron and Radiopharmacy Infrastructure Enhance Supply Efficiency
    • Emergence of AI in Image Interpretation Propels Integration with Biomarker-Specific Tracers
    • Surge in Neurology Imaging Drives Demand for PET Tracers in Alzheimer's and Parkinson's Diagnostics
    • Increased PET Application in Cardiovascular Imaging Expands Beyond Oncology Use Cases
    • R&D in Fluorine-18 and Gallium-68 Radiochemistry Fuels Development of Novel Agents
    • Strategic Collaborations Between Pharma and Imaging Providers Drive Companion Tracer Commercialization
    • Regulatory Streamlining of Investigational New Drug (IND) Applications Supports Faster Innovation Cycles
    • Limited Half-Life and Logistics of Short-Lived Isotopes Spur Investment in Decentralized Production
    • Growth in PET-Guided Biopsies and Therapeutic Planning Enhances Clinical Utility of Tracers
    • Clinical Trial Activity in Targeted Immunotherapies Spurs Use of Novel Radioligands
    • Rising Investments in Academic Radiochemistry Programs Expands Pipeline of First-in-Class Tracers
    • PET Radiotracer Market Expansion in Asia-Pacific Driven by Diagnostic Infrastructure Growth
    • Shift Toward Outpatient Imaging and Mobile PET Units Sustains Demand for On-Site Radiotracer Solutions
    • Increased Demand for Theranostic Pairings with Radiopharmaceutical Therapeutics Spurs Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World PET Radiotracers Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for PET Radiotracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for PET Radiotracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for PET Radiotracers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for F-18 Radiotracer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for F-18 Radiotracer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for F-18 Radiotracer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Ga 68 Radiotracer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Ga 68 Radiotracer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Ga 68 Radiotracer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Radiotracer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Radiotracer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Radiotracer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostic Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Diagnostic Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Diagnostic Centers End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Heart Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Heart Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Heart Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Gastrointestinal Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Gastrointestinal Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Gastrointestinal Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Endocrine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Endocrine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Endocrine Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Neurological Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Neurological Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Neurological Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: USA 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: USA 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: USA 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • JAPAN
    • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • CHINA
    • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: China 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: China 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: China 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • EUROPE
    • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for PET Radiotracers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for PET Radiotracers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for PET Radiotracers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • FRANCE
    • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: France 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: France 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: France 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • GERMANY
    • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: UK 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: UK 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: UK 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Spain 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Russia 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for PET Radiotracers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for PET Radiotracers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Australia 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • INDIA
    • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: India 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: India 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: India 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: South Korea 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for PET Radiotracers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for PET Radiotracers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for PET Radiotracers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Latin America 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Argentina 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 229: Brazil 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 238: Mexico 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for PET Radiotracers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for PET Radiotracers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for PET Radiotracers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 259: Middle East 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 268: Iran 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 277: Israel 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 295: UAE 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030
  • AFRICA
    • PET Radiotracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for PET Radiotracers by Radiotracer - F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for PET Radiotracers by Radiotracer - Percentage Breakdown of Value Sales for F-18 Radiotracer, Ga 68 Radiotracer and Other Radiotracer Types for the Years 2014, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for PET Radiotracers by End-user - Hospitals End-User, Diagnostic Centers End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for PET Radiotracers by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Diagnostic Centers End-User and Other End-Users for the Years 2014, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for PET Radiotracers by Application - Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 313: Africa 16-Year Perspective for PET Radiotracers by Application - Percentage Breakdown of Value Sales for Cancer Application, Heart Disease Application, Gastrointestinal Application, Endocrine Application, Neurological Disorders Application and Other Applications for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제